Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class ASSE: 600329

Report for Q3 2024

Oct 31, 2024 · Issued by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A via Shanghai Stock Exchange

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment